1. Acalabrutinib Versus Investigator's Choice in Relapsed/Refractory Chronic Lymphocytic Leukemia: Final ASCEND Trial Results. Issue 12 (14th December 2022) Authors: Ghia, Paolo; Pluta, Andrzej; Wach, Małgorzata; Lysak, Daniel; Šimkovič, Martin; Kriachok, Iryna; Illés, Árpád; de la Serna, Javier; Dolan, Sean; Campbell, Philip; Musuraca, Gerardo; Jacob, Abraham; Avery, Eric J.; Lee, Jae Hoon; Usenko, Ganna; Wang, Min Hui; Yu, Ting; Jurczak, Wojciech Journal: HemaSphere Issue: Volume 6:Issue 12(2022) Page Start: e801 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗